BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/24/2021 2:07:00 AM | Browse: 540 | Download: 1494
 |
Received |
|
2021-02-01 15:08 |
 |
Peer-Review Started |
|
2021-02-01 15:34 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-03-07 06:31 |
 |
Revised |
|
2021-04-06 08:38 |
 |
Second Decision |
|
2021-05-18 09:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-05-18 22:40 |
 |
Articles in Press |
|
2021-05-18 22:40 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-07-02 09:29 |
 |
Typeset the Manuscript |
|
2021-08-16 01:52 |
 |
Publish the Manuscript Online |
|
2021-08-24 02:07 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Case Report |
Article Title |
Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stopgain mutation: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Qu Lin, Ming-Jun Bai, Hao-Fan Wang, Xiang-Yuan Wu, Ming-Sheng Huang and Xing Li |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Guangzhou Science and Technology Project |
201904010461 |
Major Talents Project of Guangdong Province |
2019TQ05Y266 |
|
Corresponding Author |
Xing Li, MD, Professor, Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou 510630, Guangdong Province, China. lixing9@mail.sysu.edu.cn |
Key Words |
Hepatocellular carcinoma; Mutation; Wnt pathway; Aspirin; Adenomatous polyposis coli; Case report |
Core Tip |
Hepatocellular carcinoma (HCC) is a highly heterogeneous disease. Due to the differences in etiology and ethnicities, the driving genes in HCC are likely to be different globally. Adenomatous polyposis coli (APC) mutations are critical in a fraction of HCC patients, as APC mutations might trigger HCC by activating the Wnt pathway. The effects of this mutation could be consistently suppressed by aspirin. Thus, APC mutation-triggered HCC might be a new subgroup of chronic hepatitis B virus infection-related HCC. Wnt pathway inhibition could be an effective remedy for this subgroup of patients. |
Publish Date |
2021-08-24 02:07 |
Citation |
Lin Q, Bai MJ, Wang HF, Wu XY, Huang MS, Li X. Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stopgain mutation: A case report. World J Clin Cases 2021; 9(24): 7189-7195 |
URL |
https://www.wjgnet.com/2307-8960/full/v9/i24/7189.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v9.i24.7189 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345